Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

Mise à jour : Il y a 4 ans
Référence : NCT01593228

Femme et Homme

Extrait

The purpose of this study is to assess the safety and tolerability of iniparib administered as monotherapy or in combination regimens in patients previously treated with iniparib in a clinical study and who have derived clinical benefit after completion of the parental study's objectives.


Critère d'inclusion

  • Solid Tumors


Liens